Comparison of pharmacokinetics and pharmacodynamics of one-week monotherapy with IS-5-N s.r. 50 or 100 mg, ISDN s.r. 120 mg or IS-5-N 2 x 20 mg in coronary heart disease patients.
Jansen
W
W
Medizinische Klinik I, Städtisches Krankenhaus Leverkusen, Germany.
Prenzel
R
R
Düring
C
C
Rappert
B
B
Geppert
R
R
D001794:Blood Pressure / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D007548:Isosorbide Dinitrate / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D011651:Pulmonary Artery / Q000187:drug effects; D014665:Vasodilator Agents / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use
D014665:Vasodilator Agents; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate